Gene · 3806
Papers1,400
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,400
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synthetic tunable promoters for flexible control of multi-gene expression in mammalian cells. | J Adv Res | 2025 | 39938795 | PubTator, text mining | PubMed |
| NK-cell cytotoxicity toward pluripotent stem cells and their neural progeny: impacts of activating and inhibitory receptors and KIR/HLA mismatch. | Stem Cells | 2025 | 39708357 | PubTator, text mining | PubMed |
| Acute natural killer cells response to a continuous moderate intensity and a work-matched high intensity interval exercise session in metastatic cancer patients treated with chemotherapy. | Brain Behav Immun Health | 2024 | 39155952 | PubTator, text mining | PubMed |
| Association between Killer Immunoglobulin-like receptor genes and susceptibility to inflammatory bowel disease: An updated meta-analysis. | Heliyon | 2024 | 39100457 | PubTator, text mining | PubMed |
| The effects of killer cell immunoglobulin-like receptor (KIR) genes on susceptibility to severe COVID-19 in the Iranian population. | BMC Immunol | 2024 | 38943065 | PubTator, text mining | PubMed |
| Interconnected lineage trajectories link conventional and natural killer (NK)-like exhausted CD8+ T cells beneficial in type 1 diabetes. | Commun Biol | 2024 | 38937521 | PubTator, text mining | PubMed |
| NK cell receptor profiling of endometrial and decidual NK cells reveals pregnancy-induced adaptations. | Front Immunol | 2024 | 38571943 | PubTator, text mining | PubMed |
| The role of TIM3+ NK and TIM3- NK cells in the immune pathogenesis of severe aplastic anemia. | J Transl Int Med | 2024 | 38525441 | PubTator, text mining | PubMed |
| HLA-G isoforms, HLA-C allotype and their expressions differ between early abortus and placenta in relation to spontaneous abortions. | Placenta | 2024 | 38492472 | PubTator, text mining | PubMed |
| Obtaining Gene-Modified HLA-E-Expressing Feeder Cells for Stimulation of Natural Killer Cells. | Pharmaceutics | 2024 | 38276503 | PubTator, text mining | PubMed |
KIR2DS1 and KIR2DL1-C245 Dominantly Repress NK Cell Degranulation Triggered by Monoclonal or Bispecific Antibodies, whereas Education by Uptuning Inhibitory Killer Ig-related Receptors Exerts No Advantage in Ab-dependent Cellular Cytotoxicity. | J Immunol | 2024 | 38240527 | PubTator, text mining | PubMed |
| Association of KIR Genes with Middle East Respiratory Syndrome Coronavirus Infection in South Koreans. | J Clin Med | 2024 | 38202265 | PubTator, text mining | PubMed |
| Non-invasive molecular biomarkers for monitoring solid organ transplantation: A comprehensive overview. | Int J Immunogenet | 2024 | 38200592 | PubTator, text mining | PubMed |
| Structural basis for the activity and specificity of the immune checkpoint inhibitor lirilumab. | Sci Rep | 2024 | 38185735 | PubTator, text mining | PubMed |
| Donor aKIR genes influence the risk of EBV and CMV reactivation after anti-thymocyte globulin-based haploidentical hematopoietic stem cell transplantation. | HLA | 2024 | 38081622 | PubTator, text mining | PubMed |
| Systematic evaluation of donor-KIR/recipient-HLA interactions in HLA-matched hematopoietic cell transplantation for AML. | Blood Adv | 2024 | 38052043 | PubTator, text mining | PubMed |
| Association of recurrent implantation failure and recurrent pregnancy loss with peripheral blood natural killer cells and interferon-gamma level. | Obstet Gynecol Sci | 2024 | 37986570 | PubTator, text mining | PubMed |
| Immune system cells modulation in patients with reproductive issues: A systematic review approach. | JBRA Assist Reprod | 2024 | 37962966 | PubTator, text mining | PubMed |
| Impact of HLA Class I Antigen, Killer Inhibitory Receptor, and FCGR3A Genotypes on Breast Cancer Susceptibility and Tumor Stage. | Curr Mol Med | 2024 | 37461339 | PubTator, text mining | PubMed |
| Persistence of KIRneg NK cells after haploidentical hematopoietic stem cell transplantation protects from human cytomegalovirus infection/reactivation. | Front Immunol | 2023 | 38268918 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3806/papers?page=2